Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Green Mountain Development Corp. (GMND)
Carlsbad, CA, US
Green Mountain Development Corp. provides project development services for capital providers and technology operators; and distributes licensed products related to the energy, agricultural, and environmental sectors. The company assists clients with preliminary development work, including project due diligence, investor presentations, identification of project capital sources and technology vendors, and negotiation of a joint venture agreement between investors and the client. It also distributes Bio-Miracle microbial blends that are used for agricultural growth enhancement, composting acceleration, pond and lake water treatment, hydrocarbon reduction in soil and water, and animal and green waste treatment. The Bio-Miracle product lines include Remediline remediation products comprising SPILL KILL PRO, an oil spill cleanup product for soil and tank applications, and SIZZLE CLEAN, a microbe water based fizzing tablet for parts cleaning applications; Wasteline waste management products consisting of MANURE KING for cow/horse/pig manure control and SPARKLE CLEAN for septic and cesspool cleanup; and Bi-Agra agricultural products for increased plant health, size, and yield improvement, such as Bi-Agra-100, Bi-Agra-200, TOO TALL TOMATOES, and COMPOST PAL for backyard and commercial composting acceleration, as well as non-invasive dethatch applications. In addition, it focuses on the research, development, and production of a range of life science products. The company is based in Carlsbad, California.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | +0.00% | -50.00% | +0.00% | +0.00% | +0.00% | +0.00% | -98.58% | -80.00% | -93.33% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
-
Revenue growth Consulting Services: +8.7%-53.6%
-
EPS growth Consulting Services: +10.0%+25.0% ★
-
FCF margin FCF growth · Consulting Services: +16.4%-429.9%
-
EBIT margin Consulting Services: +14.1%-480.0%
-
ROIC Consulting Services: +12.0%-871.9%
-
Share dilution Consulting Services: +0.6%+77.0%
-
Debt / EBITDA Net debt/EBITDA · Consulting Services: -0.79×-0.24×
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Robert C. Brehm | Chairman, Chief Executive Officer, President, Secretary, Chairman, CEO & President of U S Microbics Inc | 18.0K | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for GMND
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
